Trials / Not Yet Recruiting
Not Yet RecruitingNCT07177456
Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury
Study on the Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in the Treatment of Radiation-induced Lung Injury
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the safety and efficacy of the umbilical cord blood mononuclear cells (UCB-MNCs) therapy for radiation-induced lung injuryr (RILI) by observing factors related to the therapeutic effect and adverse reactions of UCB-MNCs in treating RILI .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | UCB-MNCs | UCB-MNCs were administered via intravenous infusion three times, once per week, with a dose of 3×10⁸ cells per infusion. |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-10-31
- Completion
- 2026-12-31
- First posted
- 2025-09-17
- Last updated
- 2025-09-17
Source: ClinicalTrials.gov record NCT07177456. Inclusion in this directory is not an endorsement.